Cargando…

Clinical Proteomics of Biofluids in Haematological Malignancies

Since the emergence of high-throughput proteomic techniques and advances in clinical technologies, there has been a steady rise in the number of cancer-associated diagnostic, prognostic, and predictive biomarkers being identified and translated into clinical use. The characterisation of biofluids ha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dunphy, Katie, O’Mahoney, Kelly, Dowling, Paul, O’Gorman, Peter, Bazou, Despina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8348619/ https://www.ncbi.nlm.nih.gov/pubmed/34360786 http://dx.doi.org/10.3390/ijms22158021

Ejemplares similares

Current Methods of Post-Translational Modification Analysis and Their Applications in Blood Cancers
por: Dunphy, Katie, et al.
Publicado: (2021)

Proteomic and Metabolomic Analysis of Bone Marrow and Plasma from Patients with Extramedullary Multiple Myeloma Identifies Distinct Protein and Metabolite Signatures
por: Dunphy, Katie, et al.
Publicado: (2023)

Identification of Protein Biomarker Signatures for Acute Myeloid Leukemia (AML) Using Both Nontargeted and Targeted Approaches
por: Dowling, Paul, et al.
Publicado: (2021)

Using Proteomics Data to Identify Personalized Treatments in Multiple Myeloma: A Machine Learning Approach
por: Katsenou, Angeliki, et al.
Publicado: (2023)

Smoldering multiple myeloma: prevalence and current evidence guiding treatment decisions
por: Blum, Agnieszka, et al.
Publicado: (2018)

Next generation proteomics with drug sensitivity screening identifies sub-clones informing therapeutic and drug development strategies for multiple myeloma patients
por: Tierney, Ciara, et al.
Publicado: (2021)

Marizomib: A novel therapeutic approach for the treatment of central nervous system myeloma
por: Bazou, Despina, et al.
Publicado: (2020)

Proteomic Research of Extracellular Vesicles in Clinical Biofluid
por: Fan, Shipan, et al.
Publicado: (2023)

Novel panel of protein biomarkers to predict response to bortezomib-containing induction regimens in multiple myeloma patients
por: Ting, Kay Reen, et al.
Publicado: (2017)

Proteomic Approaches for the Discovery of Biofluid Biomarkers of Neurodegenerative Dementias
por: Carlyle, Becky C., et al.
Publicado: (2018)

Targeting Proteotoxic Stress in Cancer: A Review of the Role that Protein Quality Control Pathways Play in Oncogenesis
por: Ho Zhi Guang, Matthew, et al.
Publicado: (2019)

An Update on Isolation Methods for Proteomic Studies of Extracellular Vesicles in Biofluids
por: Li, Jing, et al.
Publicado: (2019)

Multi-parametric single cell evaluation defines distinct drug responses in healthy hematologic cells that are retained in corresponding malignant cell types
por: Majumder, Muntasir M., et al.
Publicado: (2020)

Bone Disease in Multiple Myeloma: Pathophysiology and Management
por: Hameed, Abdul, et al.
Publicado: (2014)

Measuring Daylight: A Review of Dosimetry in Daylight Photodynamic Therapy
por: O’Mahoney, Paul, et al.
Publicado: (2019)

The In Vitro Cytotoxic Activity of Murine Iso-antisera on Normal and Malignant Cells*
por: O'Gorman, Patrick
Publicado: (1960)

A qualitative evidence synthesis of healthcare professionals’ experiences and views of palliative care for patients with a haematological malignancy
por: Dowling, Maura, et al.
Publicado: (2020)

Tuberculosis in Patients with Haematological Malignancies
por: Anibarro, Luis, et al.
Publicado: (2014)

S100 Calcium Binding Protein Family Members Associate With Poor Patient Outcome and Response to Proteasome Inhibition in Multiple Myeloma
por: Liu, Minxia, et al.
Publicado: (2021)

Overview of Biofluids and Flow Sensing Techniques Applied in Clinical Practice
por: Yáñez, Carlos, et al.
Publicado: (2022)

Cancer stem cells in haematological malignancies
por: Zagozdzon, Radoslaw, et al.
Publicado: (2015)

The hypoxia signalling pathway in haematological malignancies
por: Irigoyen, Marta, et al.
Publicado: (2017)

The Application of CAR-T Cells in Haematological Malignancies
por: Skorka, Katarzyna, et al.
Publicado: (2020)

Targeting hypoxia in solid and haematological malignancies
por: Harris, Bill, et al.
Publicado: (2022)

Clinical use of rituximab in haematological malignancies
por: Avivi, I, et al.
Publicado: (2003)

HAEMATOLOGY IN TROPICAL AREAS: CLINICS IN HAEMATOLOGY
Publicado: (1983)

The Role of miRNA in Haematological Malignancy
por: Gounaris-Shannon, Stephanie, et al.
Publicado: (2013)

Breast imaging findings in haematological malignancies
por: Glazebrook, K. N., et al.
Publicado: (2014)

Low-dose daylight exposure induces nitric oxide release and maintains cell viability in vitro
por: Hazell, Gareth, et al.
Publicado: (2023)

Long covid: risk factors, outcomes, and future directions for research
por: O'Mahoney, Lauren, et al.
Publicado: (2022)

Alteration of Sphingolipids in Biofluids: Implications for Neurodegenerative Diseases
por: Pujol-Lereis, Luciana M.
Publicado: (2019)

PARP Inhibitors and Haematological Malignancies—Friend or Foe?
por: Skelding, Kathryn A., et al.
Publicado: (2021)

Beta-D-Glucan in Patients with Haematological Malignancies
por: Mikulska, Malgorzata, et al.
Publicado: (2021)

Overview of Histone Deacetylase Inhibitors in Haematological Malignancies
por: Bishton, Mark J., et al.
Publicado: (2010)

Long Non-Coding RNAs in Haematological Malignancies
por: Garitano-Trojaola, Andoni, et al.
Publicado: (2013)

Components of the Lectin Pathway of Complement in Haematologic Malignancies
por: Cedzyński, Maciej, et al.
Publicado: (2020)

Ferroptosis in Haematological Malignancies and Associated Therapeutic Nanotechnologies
por: Mynott, Rachel L., et al.
Publicado: (2023)

CLINICS IN HAEMATOLOGY
Publicado: (1975)

Nuclear magnetic resonance spectroscopy of biofluids for osteoarthritis
por: Clarke, Emily J, et al.
Publicado: (2020)

Survival of critically ill patients with haematological malignancies compared with patients without haematological malignancy
por: Pugh, R, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_brrpb6gm7aidqpeq5shl8k3kiq